FDA Approves First Pill to Treat Moderate-to-Severe Crohn Disease

FRIDAY, May 19, 2023 -- Patients with Crohn disease have a new treatment option, following U.S. Food and Drug Administration approval of Rinvoq (upadacitinib).
Rinvoq is meant to treat adults with moderately to severely active Crohn disease who have...